VI
NVRO

Versor Investments’s NEVRO CORP. NVRO Stock Holding History

Versor Investments’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,017
Closed -$212K – 890
2023
Q3 		$212K Buy
11,017
+2,050
+23% +$43.7K 0.04% 579
2023
Q2 		$228K Sell
8,967
-9,069
-50% -$262K 0.04% 521
2023
Q1 		$652K Buy
18,036
+7,336
+69% +$258K 0.09% 228
2022
Q4 		$424K Buy
+10,700
New +$445K 0.04% 400

Other funds holding NVRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Versor Investments's NVRO Position: Q4 2023 in Review

Versor Investments sold out of NEVRO CORP. (NVRO) in Q4 2023, closing a stake of 11,017 shares — an estimated $212K sold.

Versor Investments first reported a position in NVRO in Q4 2022 and held it in 4 quarters. The position peaked at $652K in Q1 2023. 140 funds tracked by Wall St. Rank hold NVRO as of Q4 2023.

  • Versor Investments reported no remaining NEVRO CORP. position as of Q4 2023 after selling out during the quarter.
  • Versor Investments sold 11,017 NEVRO CORP. shares in Q4 2023, an estimated $212K.
  • Versor Investments first reported a position in NEVRO CORP. in Q4 2022 and held it in 4 quarters.
  • Versor Investments's NEVRO CORP. position peaked at $652K in Q1 2023.
  • 140 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2023.

Based on Versor Investments's 13F filing for Q4 2023, filed 7 Feb 2024.